Quarterly report pursuant to Section 13 or 15(d)

Joint Venture and Options Transaction (Details)

v3.20.2
Joint Venture and Options Transaction (Details) - USD ($)
 3 Months Ended
Mar. 01, 2020
Dec. 23, 2019
Jun. 24, 2019
Feb. 04, 2019
Jan. 29, 2019
Oct. 31, 2018
Aug. 31, 2020
Aug. 31, 2019
Joint Venture and Options Transaction (Details) [Line Items]                
Financing Receivable, after Allowance for Credit Loss, Current           $ 5,000,000    
Note Receivable, Interest Rate, Stated Percentage           6.00%    
Interest Costs Capitalized             $ 212,601 $ 136,190
Proceeds from Collection of Notes Receivable             750,000 0
Payments to Acquire Notes Receivable             0 175,000
Joint Venture with CannAssist [Member]                
Joint Venture and Options Transaction (Details) [Line Items]                
Interest Income, Related Party             1,638 12,536
Proceeds from Collection of Notes Receivable   $ 342,567            
Financing Receivable, after Allowance for Credit Loss     $ 325,000          
Debt Instrument, Face Amount         $ 500,000      
Line of Credit Facility, Description         Any draws on the line of credit in excess of $150,000 will only be made in the sole discretion of the Company      
Debt Instrument, Interest Rate, Stated Percentage         8.00%      
Payments to Acquire Notes Receivable     $ 175,000 $ 150,000        
Principal [Member] | Joint Venture with CannAssist [Member]                
Joint Venture and Options Transaction (Details) [Line Items]                
Proceeds from Collection of Notes Receivable   325,000            
Accrued Interest [Member] | Joint Venture with CannAssist [Member]                
Joint Venture and Options Transaction (Details) [Line Items]                
Proceeds from Collection of Notes Receivable   $ 17,567            
In Good Health [Member]                
Joint Venture and Options Transaction (Details) [Line Items]                
Business Combination, Consideration Transferred           $ 47,500,000    
Payments to Acquire Businesses, Gross           35,000,000    
Business Combination, Consideration Transferred, Liabilities Incurred           7,500,000    
Interest Income, Related Party             60,565 $ 75,616
Interest Costs Capitalized $ 399,453              
Proceeds from Collection of Notes Receivable             750,000  
Financing Receivable, after Allowance for Credit Loss             3,353,306  
Interest Receivable             2,756  
Option Agreement, Brake-Up Fee           $ 2,500,000    
Interest Rate, Default           15.00%    
Debt Instrument, Interest Rate, Stated Percentage           6.00%    
In Good Health [Member] | Principal [Member]                
Joint Venture and Options Transaction (Details) [Line Items]                
Proceeds from Collection of Notes Receivable             688,869  
In Good Health [Member] | Accrued Interest [Member]                
Joint Venture and Options Transaction (Details) [Line Items]                
Proceeds from Collection of Notes Receivable             $ 61,131  
Option Agreement [Member] | In Good Health [Member]                
Joint Venture and Options Transaction (Details) [Line Items]                
Business Combination, Consideration Transferred           $ 47,500,000    
Payments to Acquire Businesses, Gross           35,000,000    
Business Combination, Consideration Transferred, Liabilities Incurred           7,500,000    
Business Combination, Consideration Transferred, Other           $ 2,500,000    
Debt Instrument, Term           5 years    
Option Agreement [Member] | Restricted Stock [Member] | In Good Health [Member]                
Joint Venture and Options Transaction (Details) [Line Items]                
Equity Issued in Business Combination, Fair Value Disclosure           $ 5,000,000